Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Lexicon Pharmaceuticals Inc (NASDAQ:LXRX)

8.51
Delayed Data
As of 2:22pm ET
 +0.04 / +0.47%
Today’s Change
5.60
Today|||52-Week Range
11.90
+33.61%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues1.8M1.1M2.2M22.9M
 
 
 
 
 
Depreciation And Amortization4.9M4.2M2.9M1.9M
 
 
 
 
 
 
Operating ExpensesGross Income-3.0M------
 
 
General Expenses103.5M95.4M103.9M101.2M
 
 
 
 
 
Research And Development91.8M78.4M89.7M84.4M
 
 
 
 
 
Total Operating Expenses108.4M99.6M106.8M103.1M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-106.5M-98.5M-104.6M-80.2M
 
 
 
 
 
Extraordinary Credit0.000.002.2M--
 
 
Extraordinary Charge-7.6M-9.9M0.00-20.1M
 
 
 
 
Interest Expense On Debt2.5M2.1M2.0M2.3M
 
 
 
 
 
Other Expenses153.0K105.0K59.0K2.3M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-116.2M-110.2M-104.1M-100.4M
 
 
 
 
 
Income Taxes0.000.000.00-70.0K
 
 
Net Income-116.2M-110.2M-104.1M-100.3M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS48.7M70.0M73.3M76.3M
 
 
 
 
 
Shares To Calculate EPS Diluted48.7M70.0M73.3M76.3M
 
 
 
 
 
 
Earnings Per ShareEPS-$2.38-$1.61-$1.40-$1.33
 
 
 
 
 
EPS Diluted-$2.38-$1.61-$1.40-$1.33